A detailed history of Foundation Resource Management Inc transactions in Sanofi stock. As of the latest transaction made, Foundation Resource Management Inc holds 273,321 shares of SNY stock, worth $13 Million. This represents 2.44% of its overall portfolio holdings.

Number of Shares
273,321
Previous 275,083 0.64%
Holding current value
$13 Million
Previous $13.3 Million 18.07%
% of portfolio
2.44%
Previous 2.13%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$48.54 - $58.53 $85,527 - $103,129
-1,762 Reduced 0.64%
273,321 $15.8 Million
Q2 2024

Jul 10, 2024

SELL
$45.39 - $50.36 $15,251 - $16,920
-336 Reduced 0.12%
275,083 $13.3 Million
Q1 2024

Apr 11, 2024

BUY
$45.75 - $52.48 $248,102 - $284,599
5,423 Added 2.01%
275,419 $13.4 Million
Q4 2023

Jan 10, 2024

BUY
$43.13 - $54.79 $155,354 - $197,353
3,602 Added 1.35%
269,996 $13.4 Million
Q3 2023

Oct 10, 2023

SELL
$50.95 - $55.2 $54,159 - $58,677
-1,063 Reduced 0.4%
266,394 $14.3 Million
Q2 2023

Jul 12, 2023

BUY
$50.45 - $57.18 $228,942 - $259,482
4,538 Added 1.73%
267,457 $14.4 Million
Q1 2023

Apr 11, 2023

BUY
$45.86 - $54.45 $238,930 - $283,684
5,210 Added 2.02%
262,919 $14.3 Million
Q4 2022

Jan 12, 2023

BUY
$38.86 - $48.55 $34,740 - $43,403
894 Added 0.35%
257,709 $12.5 Million
Q3 2022

Oct 13, 2022

BUY
$37.22 - $100.5 $270,552 - $730,534
7,269 Added 2.91%
256,815 $9.76 Million
Q2 2022

Jul 15, 2022

BUY
$48.99 - $57.46 $39,094 - $45,853
798 Added 0.32%
249,546 $12.5 Million
Q1 2022

Apr 12, 2022

BUY
$48.48 - $53.65 $398,651 - $441,163
8,223 Added 3.42%
248,748 $12.8 Million
Q4 2021

Jan 21, 2022

SELL
$47.07 - $52.35 $11.3 Million - $12.6 Million
-240,525 Reduced 50.0%
240,525 $12.1 Million
Q4 2021

Jan 12, 2022

BUY
$47.07 - $52.35 $11.6 Million - $12.9 Million
246,653 Added 105.23%
481,050 $24.1 Million
Q3 2021

Oct 12, 2021

BUY
$47.89 - $53.12 $343,945 - $381,507
7,182 Added 3.16%
234,397 $11.3 Million
Q2 2021

Jul 13, 2021

SELL
$49.36 - $54.25 $210,026 - $230,833
-4,255 Reduced 1.84%
227,215 $12 Million
Q1 2021

Apr 08, 2021

SELL
$45.46 - $50.51 $157,700 - $175,219
-3,469 Reduced 1.48%
231,470 $11.4 Million
Q4 2020

Jan 13, 2021

SELL
$45.3 - $51.62 $36,919 - $42,070
-815 Reduced 0.35%
234,939 $11.4 Million
Q3 2020

Oct 07, 2020

SELL
$49.47 - $53.77 $276,191 - $300,197
-5,583 Reduced 2.31%
235,754 $11.8 Million
Q2 2020

Jul 08, 2020

SELL
$42.91 - $52.5 $262,051 - $320,617
-6,107 Reduced 2.47%
241,337 $12.3 Million
Q1 2020

Apr 08, 2020

SELL
$38.02 - $51.66 $3.18 Million - $4.32 Million
-83,691 Reduced 25.27%
247,444 $10.8 Million
Q4 2019

Jan 08, 2020

SELL
$44.25 - $50.86 $128,723 - $147,951
-2,909 Reduced 0.87%
331,135 $16.6 Million
Q3 2019

Oct 03, 2019

SELL
$40.34 - $46.64 $137,882 - $159,415
-3,418 Reduced 1.01%
334,044 $15.5 Million
Q2 2019

Jul 10, 2019

SELL
$40.43 - $44.3 $49,567 - $54,311
-1,226 Reduced 0.36%
337,462 $14.6 Million
Q1 2019

Apr 11, 2019

SELL
$40.83 - $45.43 $607,142 - $675,544
-14,870 Reduced 4.21%
338,688 $15 Million
Q4 2018

Jan 17, 2019

BUY
$41.48 - $45.59 $16,343 - $17,962
394 Added 0.11%
353,558 $15.3 Million
Q3 2018

Oct 02, 2018

SELL
$40.0 - $44.84 $40,400 - $45,288
-1,010 Reduced 0.29%
353,164 $15.8 Million
Q2 2018

Jul 11, 2018

BUY
$37.63 - $41.22 $60,057 - $65,787
1,596 Added 0.45%
354,174 $14.2 Million
Q1 2018

Apr 19, 2018

SELL
$38.98 - $45.76 $786,850 - $923,711
-20,186 Reduced 5.42%
352,578 $14.1 Million
Q4 2017

Jan 10, 2018

SELL
$42.86 - $50.61 $75,905 - $89,630
-1,771 Reduced 0.47%
372,764 $16 Million
Q3 2017

Oct 11, 2017

BUY
$47.04 - $50.34 $17.6 Million - $18.9 Million
374,535
374,535 $18.6 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Foundation Resource Management Inc Portfolio

Follow Foundation Resource Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundation Resource Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foundation Resource Management Inc with notifications on news.